Skip to main content

Table 4 Multivariate analysis for recurrence-free survival (RFS) and overall survival (OS)

From: Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer

 

RFS

OS

 

HR

Conf. int.

p-value

HR

Conf. int.

p-value

Normal ECOG

0.5212

0.28515

0.9526

0.521

0.4027

0.2384

0.6804

< 0.001

No smoking history

0.4191

0.09899

1.7739

0.237

0.4887

0.1733

1.3786

0.176

Chemotherapy

(full dose)

0.9337

0.50318

1.7328

0.828

0.8130

0.4757

1.3892

0.449

Tumor volume

1.0111

1.00454

1.0177

0.036

1.0077

1.0016

1.0138

0.013

NLR

3.0218

1.67305

5.4579

< 0.001

1.7333

1.0462

2.8718

0.033